Concepedia

Stephanie Blencke

SB

Statistics

Publications

10

Citations

1.4K

H-Index

10

Active since

2001

Affiliations

Max Planck Institute of Biochemistry(Current)

Phenex Pharmaceuticals (Germany)

Vichem Chemie (Hungary)

Technische Universität Braunschweig

Semmelweis University

Stephanie Blencke is an author at Max Planck Institute of Biochemistry specializing in medicine, natural sciences, and proteomics.

Top concepts

Publications per year

2001–2012

10

Publications

10

An efficient proteomics method to identify the cellular targets of protein kinase inhibitors

Klaus Godl, Josef Wissing, Alexander Kurtenbach et al. · Proceedings of the National Academy of Sciences · 2003 · 333 citations · Full text

Cellular Targets of Gefitinib

Dirk Brehmer, Zoltán Greff, Klaus Godl et al. · Cancer Research · 2005 · 239 citations · Full text

Identification of SRPK1 and SRPK2 as the Major Cellular Protein Kinases Phosphorylating Hepatitis B Virus Core Protein

Henrik Daub, Stephanie Blencke, Peter Habenberger et al. · Journal of Virology · 2002 · 147 citations · Full text

, , +16

Characterization of a Conserved Structural Determinant Controlling Protein Kinase Sensitivity to Selective Inhibitors

Stephanie Blencke, Birgit Zech, Ola Engkvist et al. · Chemistry & Biology · 2004 · 142 citations · Full text

, , +8

Phosphosignature Predicts Dasatinib Response in Non-small Cell Lung Cancer

Martin Klammer, Marc Kaminski, Alexandra Zedler et al. · Molecular & Cellular Proteomics · 2012 · 119 citations · Full text

1–5 of 10